Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Payables (2016 - 2025)

Iradimed (IRMD) has disclosed Payables for 13 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Payables fell 4.01% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 4.01% year-over-year, with the annual reading at $1.8 million for FY2025, 4.01% down from the prior year.
  • Payables for Q4 2025 was $1.8 million at Iradimed, down from $2.3 million in the prior quarter.
  • The five-year high for Payables was $9.8 million in Q4 2023, with the low at $618217.0 in Q1 2021.
  • Average Payables over 5 years is $1.9 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Payables surged 446.49% in 2023, then plummeted 80.72% in 2024.
  • Over 5 years, Payables stood at $782903.0 in 2021, then skyrocketed by 129.83% to $1.8 million in 2022, then soared by 446.49% to $9.8 million in 2023, then tumbled by 80.72% to $1.9 million in 2024, then fell by 4.01% to $1.8 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $1.8 million, $2.3 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.